CL2007002876A1 - Compuesto peptidico peguilado; compuesto intermediario; composicion que comprende dicho compuesto; metodo de induccion de formacion osea en un mamifero que comprende tratar con dicho compuesto peguilado; uso de dicho compuesto para el tratamiento de - Google Patents
Compuesto peptidico peguilado; compuesto intermediario; composicion que comprende dicho compuesto; metodo de induccion de formacion osea en un mamifero que comprende tratar con dicho compuesto peguilado; uso de dicho compuesto para el tratamiento deInfo
- Publication number
- CL2007002876A1 CL2007002876A1 CL200702876A CL2007002876A CL2007002876A1 CL 2007002876 A1 CL2007002876 A1 CL 2007002876A1 CL 200702876 A CL200702876 A CL 200702876A CL 2007002876 A CL2007002876 A CL 2007002876A CL 2007002876 A1 CL2007002876 A1 CL 2007002876A1
- Authority
- CL
- Chile
- Prior art keywords
- compound
- peguiled
- mammer
- osea
- treatment
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 5
- 230000006698 induction Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82938306P | 2006-10-13 | 2006-10-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2007002876A1 true CL2007002876A1 (es) | 2008-06-06 |
Family
ID=38974655
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL200702876A CL2007002876A1 (es) | 2006-10-13 | 2007-10-05 | Compuesto peptidico peguilado; compuesto intermediario; composicion que comprende dicho compuesto; metodo de induccion de formacion osea en un mamifero que comprende tratar con dicho compuesto peguilado; uso de dicho compuesto para el tratamiento de |
Country Status (12)
Country | Link |
---|---|
AR (1) | AR063251A1 (es) |
CL (1) | CL2007002876A1 (es) |
CO (1) | CO6190624A2 (es) |
CR (1) | CR10681A (es) |
CY (1) | CY1110701T1 (es) |
DE (1) | DE602007006839D1 (es) |
ES (1) | ES2343917T3 (es) |
MA (1) | MA30873B1 (es) |
PE (1) | PE20080981A1 (es) |
PT (1) | PT2084183E (es) |
TW (1) | TW200817439A (es) |
ZA (1) | ZA200901853B (es) |
-
2007
- 2007-09-11 TW TW096133901A patent/TW200817439A/zh unknown
- 2007-10-04 PT PT07843791T patent/PT2084183E/pt unknown
- 2007-10-04 ES ES07843791T patent/ES2343917T3/es active Active
- 2007-10-04 DE DE602007006839T patent/DE602007006839D1/de active Active
- 2007-10-05 CL CL200702876A patent/CL2007002876A1/es unknown
- 2007-10-11 AR ARP070104507A patent/AR063251A1/es unknown
- 2007-10-12 PE PE2007001379A patent/PE20080981A1/es not_active Application Discontinuation
-
2009
- 2009-03-16 ZA ZA200901853A patent/ZA200901853B/xx unknown
- 2009-03-20 CR CR10681A patent/CR10681A/es not_active Application Discontinuation
- 2009-04-07 CO CO09035909A patent/CO6190624A2/es not_active Application Discontinuation
- 2009-05-07 MA MA31851A patent/MA30873B1/fr unknown
-
2010
- 2010-06-18 CY CY20101100569T patent/CY1110701T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200901853B (en) | 2010-05-26 |
CR10681A (es) | 2009-07-13 |
AR063251A1 (es) | 2009-01-14 |
ES2343917T3 (es) | 2010-08-12 |
CO6190624A2 (es) | 2010-08-19 |
MA30873B1 (fr) | 2009-11-02 |
CY1110701T1 (el) | 2015-06-10 |
PT2084183E (pt) | 2010-07-16 |
TW200817439A (en) | 2008-04-16 |
PE20080981A1 (es) | 2008-07-19 |
DE602007006839D1 (de) | 2010-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2056753A4 (en) | METHOD AND DEVICE FOR TREATING DRIVE DYSFUNCTION | |
FI20065147A (fi) | Järjestelmä ja menetelmä harjoittelun ohjaamiseksi | |
BRPI0716354A2 (pt) | "composiÇço e mÉtodo" | |
BR112013016242A2 (pt) | método de cimentação e, composição de cimentação | |
BRPI0913129A2 (pt) | método para tratamento de hiperuricemia empregando um inibidor de sglt2 e composição contendo o mesmo | |
CL2008000822A1 (es) | Metodo para el tratamiento de la obesidad usando un inhibidor sglt2. | |
EP1989587A4 (en) | LIGHT-EMITTING COMPONENT AND METHOD FOR CONTROLLING IT | |
CL2011001331A1 (es) | Clorhidrato de nalmefeno dihidratado; métodos para su preparación; composición farmacéutica que lo comprende; y uso para el tratamiento del alcoholismo. | |
DK1829592T3 (da) | Linearmotordrevet kørende forlystelse samt fremgangsmåde | |
SI2520295T1 (sl) | Postopki za preprečevanje in zdravljenje mukozitisa | |
DE602006010196D1 (de) | Zementzusammensetzungen mit umweltverträglichen entschäumern und verwendungsverfahren | |
BRPI0818544A2 (pt) | Processo para tratamento de uma combinação contendo organossilano, composição e uso de uma resina orgânica. | |
CL2008000794A1 (es) | Compuestos derivados de biarilo y heteroarilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar un trastorno de hierro. | |
ATE465229T1 (de) | Textilbehandlungsverfahren und zusammensetzung | |
BRPI0810738A2 (pt) | aparelho e método para tratar materiais com composições. | |
BRPI0909885A2 (pt) | composição decorativa e método para sua utilização | |
CL2009000803A1 (es) | Uso de una variante de igf-1 pegilada para tratar, prevenir un trastorno neuromuscular; metodo para el tratamiento, prevencion y/o demora de un trastorno neuromuscular; composicion que comprende la variante de igf-1 modificada | |
TWI372576B (en) | Organic light-emitting device and method for forming the same | |
EP2037941A4 (en) | COBALAMINE COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF MUCOSITIS | |
BRPI0819931A2 (pt) | Composições tópicas que compreendem aminoácidos não-proteogênicos e métodos de tratamento de pele | |
EP2086320A4 (en) | COMPOSITIONS AND METHODS FOR TREATING MEDUSES | |
CL2013002903A1 (es) | Composicion que comprende azadiractina; metodo para el tratamiento anti-macroincrustacion de al menos un polimeros; y su uso. | |
CL2008000093A1 (es) | Compuestos derivados de piridina, inhibidores de p2y12; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de un desorden de agregacion plaquetaria. | |
ZA200805870B (en) | One-way valve and apparatus and method of using the valve | |
CR10853A (es) | Metodo para el tratamiento de fisuras en estructuras de concreto |